BDX today
$215.22+$0.70 (+0.33%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourAscending Triangle
15 minLeaning Bearish
5 minConsolidating
Daily trend turns down below $193.80
Key levels
Resistance$221.98
Resistance$216.74
Support$209.27
Support$200.44
Latest news & SEC filings
ProductBD receives FDA 510(k) clearance for OneFlow diagnostic tests
AnalystBarclays keeps Underweight on Becton Dickinson, lifts target to $195
SEC FilingBecton Dickinson & Co filed an insider trading report (Form 4)
All BDX news →About Becton Dickinson
Becton Dickinson is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. It serves healthcare institutions, life science researchers, clinical laboratories, and the general public. The company operates worldwide, with significant sales outside the United States.
Based on the company's 10-K filed Nov 25, 2025.
NYSE · Healthcare
BECTON DICKINSON & CO (BDX)
What Is the Price Target for BDX?
SEPT Low Target
$167.00
SEPT Mid Target
$200.00
SEPT High Target
$242.00
Analyst Consensus
$200.00
Is BDX a Buy or Sell Right Now?
Thesis
- •Revenue growing 8.2% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BDX.
Start Free Trial →Is BDX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$208.17
25
Moat Score
NONE
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with BDX?
Insider Signal
SELLING
0 buys / 12 sells (90d)
Congress Signal
BUYING
5 buys / 5 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Feld Michael | officer | Sale | 76 | $15K | Oct 26, 2026 |
| Feld Michael | officer | Sale | 76 | $14K | Sep 28, 2026 |
| Feld Michael | officer | Sale | 165 | $31K | Aug 26, 2026 |
| Feld Michael | officer | Sale | 1,049 | - | Aug 20, 2026 |
| Polen Thomas E Jr | director officer | Buy | 43,278 | $7.2M | Aug 13, 2026 |
| Polen Thomas E Jr | director officer | Sale | 39,126 | $7.2M | Aug 13, 2026 |
| Polen Thomas E Jr | director officer | Sale | 4,152 | $768K | Aug 13, 2026 |
| Goette Roland | officer | Sale | 2,438 | $441K | Aug 11, 2026 |
| Garrison Michael David | officer | Sale | 1,100 | $167K | Jun 10, 2026 |
| Menziuso Peter | officer | Buy | 14,258 | - | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BDX Growth Story
Revenue YoY
8.2%
3yr Revenue CAGR
5.0%
EPS Growth YoY
-0.68%
FCF Growth YoY
-14.4%
Revenue Trend
ACCELERATING
Dark Pool Trades for BDX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BDX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:34:12 | $216.15 | 1,400 | $$303K | SELL |
| 14:32:59 | $216.38 | 1,061 | $$230K | SELL |
| 14:30:10 | $215.82 | 1,107 | $$239K | MIDPOINT |
| 14:30:10 | $215.82 | 1,027 | $$222K | MIDPOINT |
| 21:28:25 | $214.52 | 4,239 | $$909K | BUY |
5 dark pool trades shown · $$1.9M preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About BDX
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for BDX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup — $BDX (BECTON DICKINSON & CO) Price: $182.57 | Zone: $179.42 — $182.62 Conviction: HIGH | Analyst upside: +4.5% Near resistance (99% of range) — breakout watch. Strong positive news (1+ ...
Join 3,500+ traders discussing BDX in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BECTON DICKINSON & CO (BDX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BDX — frequently asked questions
What is BDX stock price today?
BECTON DICKINSON & CO (BDX) is at $215.22, up 0.33% (+$0.70) at the Nov 12, 2026 close.
Why is BDX stock moving today?
Latest BDX news — Nov 10, 2026: BD receives FDA 510(k) clearance for OneFlow diagnostic tests · Nov 10, 2026: Barclays keeps Underweight on Becton Dickinson, lifts target to $195
What is the BDX price target?
The average analyst price target for BDX is $200.00, ranging from $167 to $242, based on 10 analysts. Latest: Barclays maintains on Nov 10, 2026.
What do analysts rate BDX?
Analyst ratings for BDX: 2 Buy, 16 Hold, 0 Sell — consensus Hold.
Did BDX beat earnings?
BDX last reported on Nov 5, 2026: EPS $2.52 vs $4.07 expected — a miss of 38.1%.
What is BDX's P/E ratio?
BDX trades at a P/E of 65.0 vs a Healthcare average of 17.1.
Does BDX pay a dividend?
Yes. BDX's dividend yield is 3.61%.
What are BDX support and resistance levels?
Support: $209.27, $200.44, $193.80. Resistance: $216.74, $221.98, $227.66.
What are insiders doing with BDX?
Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.
What is the latest news on BDX?
Nov 10, 2026: BD receives FDA 510(k) clearance for OneFlow diagnostic tests · Nov 10, 2026: Barclays keeps Underweight on Becton Dickinson, lifts target to $195 · Nov 9, 2026: Becton Dickinson & Co filed an insider trading report (Form 4)